Insomnia in hemodialysis patients : a multicenter study from Morocco

Abstract EN

Previous studies have shown that insomnia is a common sleep disorder in patients with end-stage renal disease.

This study aims to determine the prevalence and risk factors of insomnia in our chronic hemodialysis (HD) patients.

This is a cross-sectional study conducted in three HD units in Morocco.

To assess the prevalence of insomnia, we used a specific questionnaire.

Patients complaining of difficulty in falling asleep and/or nocturnal awakenings occurring seven nights a week during the last month were included in the group “insomnia ;” the other patients were used as controls.

Clinical, biological, and dialysis data were recorded for each patient.

Sleep disorders and their subjective causes were also identified.

Eighty-nine percent of questioned patients admitted to having sleep disturbances of different degrees.

Insomnia was significantly associated with female gender and time of dialysis.

Age, body mass index, interdialytic weight gain, and blood pressure were similar between the two groups, as well as dialytic parameters and drug use.

There was no significant difference in the values of plasma creatinine, urea, hemoglobin, parathyroid hormone, calcium, phosphorus, C-reactive protein, and albumin between the groups.

Disorders most frequently encountered in patients with insomnia were waking up at night (90 %), difficulty falling asleep (60 %), and daytime sleepiness (60 %).

The restless legs syndrome was seen in half of these patients.

The main reported causes of insomnia were anxiety and/or depression (70 %) and bone pain (67 %).

Insomnia is common in HD patients and is frequently associated with other disorders of sleep.

Female sex and duration on dialysis are the two risk factors found in our study.

Insomnia does not appear related to any biochemical or dialysis parameters.

Increased attention should be given to the management of dialysis patients regarding the diagnosis and management of insomnia and associated sleep disorders.